A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer

Clinical trial NCT03866993 · COMPLETED

Trial details

NCT number: NCT03866993
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lung Cancer Non-small Cell Stage IV Squamous Cell Lung Cancer

Start date: 2018-12-20
Primary completion: 2020-10-08
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.